Cargando…
Prognostic value of endocan expression in cancers: evidence from meta-analysis
Endocan is a 50 kDa dermatan sulfate proteoglycan. Numerous previous studies have indicated that endocan might be an attractive prognostic tumor biomarker. However, the results of different studies are inconsistent. We conducted a meta-analysis to explore the association between endocan expression a...
Autores principales: | Huang, Xing, Chen, Chen, Wang, Xin, Zhang, Jing-yuan, Ren, Bin-hui, Ma, Da-wei, Xia, Lei, Xu, Xin-yu, Xu, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066987/ https://www.ncbi.nlm.nih.gov/pubmed/27785077 http://dx.doi.org/10.2147/OTT.S110295 |
Ejemplares similares
-
Prognostic and Diagnostic Value of Endocan in Kidney Diseases
por: Samouilidou, Elisabeth, et al.
Publicado: (2022) -
Circulating endocan and preeclampsia: a meta-analysis
por: Lan, Xia, et al.
Publicado: (2020) -
Expressions of Endocan in Patients with Meningiomas and Gliomas
por: Atukeren, Pinar, et al.
Publicado: (2016) -
MUC1 overexpression predicts worse survival in patients with non-small cell lung cancer: evidence from an updated meta-analysis
por: Huang, Xing, et al.
Publicado: (2017) -
Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)